Health — Diabetes — August 13th, 2026
Coffee consumption linked to leaner body composition and sex-specific hormone patterns
Coffee is one of the world's most widely consumed beverages, and previous research has linked its consumption to a lower risk of conditions such as type 2 diabetes and cardiovascular disease. However, the biological mechanisms behind these benefits remain unclear.
August 13th, 2026 — Source
Google Pixel Watch Adds Insulin Resistance Tracking: What It Could Reveal Before Blood Sugar Rises
Google Pixel Watch adds Insulin Resistance Trends to track blood sugar-related metabolic changes and bring Health Guardian insights to more wearables.
August 13th, 2026 — Source
Health — Diabetes — August 12th, 2026
New Smart Ring Prototype Tracks Glucose Through Sweat: What Users Need to Know
UC San Diego's CHARM smart ring tracks glucose through sweat, offering an early look at how daily wearable glucose monitoring could become less intrusive.
August 12th, 2026 — Source
Health — Diabetes — August 5th, 2026
Food-based support aids type 2 diabetes outcomes
Claudia Nau, Ph.D., from Kaiser Permanente Southern California in Pasadena, and colleagues randomly assigned 460 Medicaid-insured adults with type 2 diabetes and elevated HbA1c (≥7.5%) to usual care (153 patients), lower-dose MTG (153 patients; $100 to $170 per month), or higher-dose MTG (154 patients; $135 to $210 per month) for six months. All intervention participants received recipes and telenutrition counseling.
August 5th, 2026 — Source
Intertwined cellular processes reshape understanding of diabetes
A deeper understanding of how key cellular processes interact is reshaping perspectives on diabetes and its wide-ranging complications. New insights into the relationship between autophagy and ferroptosis are revealing how these fundamental mechanisms influence disease progression and may unlock new possibilities for managing complex metabolic conditions.
August 5th, 2026 — Source
Worse menopause symptoms may accompany type 2 diabetes
The type and severity of menopause symptoms can differ greatly among women. A number of earlier studies have suggested various reasons for those differences. A new study suggests that type 2 diabetes mellitus can play a role in significantly increasing the number and severity of menopause symptoms.
August 5th, 2026 — Source
Health — Diabetes — July 31st, 2026
New stem cell vesicles accelerate diabetic wound healing
Diabetic foot ulcers are among the most serious complications of diabetes because prolonged inflammation, poor circulation, and defective angiogenesis can leave wounds open for months and increase the risk of infection and amputation. Although extracellular vesicles from adipose-derived mesenchymal stem cells have shown regenerative potential, conventional two-dimensional culture gradually weakens stem-cell activity and secretory function. Many laboratory studies also rely on generic endothelial cells, which do not fully reproduce the behavior of the skin's microvasculature under diabetic stress. Based on these challenges, in-depth research is needed to develop more potent extracellular vesicles and clarify how they rescue senescent human dermal microvascular endothelial cells in diabetic wounds.
July 31th, 2026 — Source
Health — Diabetes — July 29th, 2026
New home test uses thigh length to detect type 2 diabetes or prediabetes
A new home test can detect type 2 diabetes or prediabetes with high accuracy. The test has been developed using artificial intelligence and large amounts of health data -- and surprisingly, one of the steps involves measuring the length of your thigh.
July 29th, 2026 — Source
The length of your upper leg could help detect diabetes
According to The Danish Diabetes Association, about 100,000 Danes are unaware that they have type 2 diabetes, and approximately half a million Danes are estimated to have a precursor to type 2 diabetes, also known as prediabetes.
July 29th, 2026 — Source
Health — Diabetes — July 24th, 2026
AI helps Stanford scientists discover "natural Ozempic" without the usual side effects
An AI-discovered natural molecule may deliver Ozempic-like weight loss without nausea, constipation, or significant muscle loss.
July 24th, 2026 — Source
Clinical trial a step forward in easing kidney dialysis shortfall
A trans-Tasman clinical trial led by University of Queensland researchers has marked a key step toward easing the kidney dialysis crisis in Australia and New Zealand. The researchers led a large-scale trial to test whether a standardized peritoneal dialysis program called TEACH-PD could reduce infections compared with existing patient training.
July 24th, 2026 — Source
The billion-dollar problem keeping Ozempic, Wegovy, and Zepbound from patients
GLP-1 drugs may be worth the money, but insurers fear the staggering cost of covering everyone who could benefit.
July 24th, 2026 — Source
Health — Diabetes — July 16th, 2026
Ozempic-like drugs have more benefits to the body than just losing weight, meta-analysis shows
A meta-analysis of 10 randomized controlled trials involving more than 23,000 participants, presented at the International Congress on Obesity (ICO 2026), hosted by the World Obesity Federation (WOF) in Mexico City, Mexico (July 15--17), shows that the GLP-1 class of obesity drugs is associated with a marked reduction in systemic inflammation beyond its anti-obesity effects, potentially explaining how the drugs can reduce cardiovascular risk factors.
July 16th, 2026 — Source
Rise of GLP-1s raises long-term affordability questions
As use of GLP-1s surged across the U.S., average total payments per user also climbed sharply, according to a new Northwestern University study that analyzed national trends in GLP-1 use and spending between 2017 and 2022. These total payments included out-of-pocket costs paid by patients as well as payments from insurers, employers and government programs.
July 16th, 2026 — Source
Health — Diabetes — July 10th, 2026
GLP-1RAs linked to lower risk of amputation in diabetes with PAD
The largest meta-analysis to date suggests GLP-1RAs may reduce major limb complications in people with type 2 diabetes and peripheral artery disease, although researchers say randomized trials are still needed to confirm a direct protective effect.
July 10th, 2026 — Source
Health — Diabetes — July 4th, 2026
New obesity figures highlight the income divide
The number of obese adults in England rose from 26% in 2019 to 30% in 2025, according to a new analysis of 55 million people. Nearly 1 in 3 adults are now obese. But averages hide a lot, and behind this one are two very different trends.
July 4th, 2026 — Source
Health — Diabetes — July 2nd, 2026
Anion gap remains pragmatic target during diabetic ketoacidosis treatment and resolution
Patients experiencing life-threatening diabetic ketoacidosis (DKA) require quick action, diligent care and close monitoring as they receive insulin infusions and other medical interventions to bring their blood glucose and ketone levels back into balance.
July 2nd, 2026 — Source
Hearing loss in diabetes patients a 'hidden epidemic'
Researchers are calling for hearing tests to become a standard part of diabetes care and for hearing loss to be recognized as a significant complication of the condition. Dr. Mehwish Nisar from UQ's School of Public Health said most people were unaware there was even a connection between hearing loss and diabetes.
July 2nd, 2026 — Source
Health — Diabetes — June 26th, 2026
Smart microneedles bend to heal diabetic wounds from within
AI-designed microneedles bend at body temperature to close diabetic wounds while delivering DNA therapy and antibacterial protection.
June 26th, 2026 — Source
Health — Diabetes — June 22nd, 2026
India's Ultrahuman Launches No-Prescription Glucose Tracking Platform in the US
Ultrahuman M2 Live brings no-prescription glucose tracking to the US using Abbott's Lingo CGM, with plans starting at $99 per month.
June 22nd, 2026 — Source
Weight‑loss drugs like Ozempic could work for addiction too—and we finally know how
For many people, the thought of a tasty burger or a cold pint of beer conjures a vivid mental image and drives behavior. This link between thinking and doing serves a clear function—it motivates us to get the necessities of life.
June 22nd, 2026 — Source
Health — Diabetes — June 20th, 2026
Ozempic changed obesity treatment, but experts say the real revolution is next
Weight-loss drugs like Ozempic and Zepbound have reshaped obesity treatment, but experts say they are only part of the solution.
June 20th, 2026 — Source
Health — Diabetes — June 19th, 2026
6 Continuous Glucose Monitors That Are Doctor-Approved
Track your glucose with these CGMs.
June 19th, 2026 — Source
This Is the First FDA-Approved OTC Continuous Glucose Monitor for Children
This popular CGM can now be marketed for children 2 years of age and older who do not use insulin.
June 19th, 2026 — Source
Health — Diabetes — June 16th, 2026
Most people who stop GLP-1 drugs like Ozempic eventually return
Many people prescribed GLP-1 drugs for type 2 diabetes (such as Victoza, Ozempic, or tirzepatide) stop taking them, but a surprising number later return to treatment. Researchers found that newer medications appear to keep patients on therapy longer, while side effects remain a major reason for discontinuation.
June 16th, 2026 — Source
Semaglutide (Ozempic) linked to fewer bone fractures despite greater weight loss
Semaglutide may help people with type 2 diabetes lose more weight while also lowering their risk of painful bone fractures.
June 16th, 2026 — Source
Health — Diabetes — June 15th, 2026
Clinical trials suggest GLP-1s may improve fertility in men with obesity
GLP-1s do not harm male hormones or fertility after long-term use, according to a study being presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago. In fact, the research team found GLP-1s may improve testosterone levels and sperm quality in men with obesity-related low testosterone, while also addressing the underlying effects of obesity.
June 15th, 2026 — Source
Cohabiting people share about a quarter of their gut and oral microbiota, study finds
The researchers also found a link between more transmissible microbes and health, particularly type 2 diabetes. The findings could help design more targeted therapies for improving people's microbiomes.
June 15th, 2026 — Source
For adults with prediabetes, lifestyle intervention lowered risk of developing multiple chronic conditions
NIH-supported, long-term clinical trial found no difference between metformin and placebo.
June 15th, 2026 — Source
Long naps may increase the risk of chronic liver disease in people with diabetes
People with type 2 diabetes who nap longer than 30 minutes every day, regardless of their sleep patterns at night, increase their risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD), according to a study being presented Monday at ENDO 2026, the Endocrine Society's annual meeting in Chicago.
June 15th, 2026 — Source
Health — Diabetes — June 10th, 2026
GLP-1s may alleviate depression through the microbiome, mouse study suggests
Some people taking GLP-1 drugs for diabetes and obesity experience mental health benefits—particularly a decrease in symptoms of depression. In a mouse model study published in Cell Host & Microbe, researchers report that these mental health improvements appear to result from changes in the gut microbiome that lead to an abundance of a microbial strain known to have a favorable effect on neurons related to stress.
June 10th, 2026 — Source
Plant-based quinoa burgers reduce post-meal blood sugar spikes
A small clinical study found that plant-based burgers made with red quinoa and baru pulp triggered smaller blood sugar spikes than pure glucose, highlighting the potential of sustainable, fiber-rich ingredients in future food formulations.
June 10th, 2026 — Source
Health — Diabetes — June 8th, 2026
New GLP-1 oral pill lowers blood sugar and reduces bodyweight, clinical trial finds
Oral GLP-1 medications have the potential to increase access to therapies that can help lower blood sugar and reduce bodyweight. At the American Diabetes Association's Scientific Session, Mass General Brigham physician investigator Vanita Aroda, MD, presented findings from SOLSTICE, a Phase IIb randomized, placebo-controlled clinical trial that tested the oral GLP-1 RA known as elecoglipron.
June 8th, 2026 — Source
Veterans with both insomnia and sleep apnea have elevated risk of developing type 2 diabetes
Results show that insomnia alone was associated with a 41% increased risk of incident type 2 diabetes overall, with a greater elevation in the risk among women (48%) than men (39%). Sleep apnea alone conferred a risk of incident diabetes that was more than five times higher in men and nearly four times higher in women. Veterans with comorbid insomnia and sleep apnea, often referred to as COMISA, had the greatest risk of incident type 2 diabetes, with an overall hazard ratio that was 6.2 times higher (6.5 times higher in men and 4.7 times higher in women), compared with those with neither disorder.
June 8th, 2026 — Source
Why one diabetes drug may sharply cut heart failure risk for genetically vulnerable patients
Rare genetic variants known to cause cardiomyopathy, an inherited cause of a weak heart, can increase the risk of patients developing heart failure. However, new research from Mass General Brigham Heart and Vascular Institute and the Broad Institute of MIT and Harvard reveals that dapagliflozin, a medication used to treat type 2 diabetes, is particularly effective at reducing the risk in individuals who are genetically predisposed to developing heart failure.
June 8th, 2026 — Source or Source
Health — Diabetes — June 7th, 2026
Engineered stem cells reverse new-onset type 1 diabetes in mice
A group of researchers at the Medical University of South Carolina (MUSC) has recently developed a new stem cell therapy with a remarkable ability to reverse new-onset type 1 diabetes (T1D) in a mouse model of the disease. The work is published in the journal Molecular Therapy.
June 7th, 2026 — Source
Infections pose major but overlooked risks in people with diabetes
In one of the largest studies to date, findings reveal that people living with type 1 diabetes, type 2 diabetes and prediabetes face higher risks of infection compared to those without diabetes. These risks span infections managed in primary care, those requiring hospital admission, and deaths related to infection.
June 7th, 2026 — Source
Health — Diabetes — June 6th, 2026
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk
Popular GLP-1 weight-loss drugs may have an unexpected bonus: a significantly lower risk of breast cancer.
June 6th, 2026 — Source
Health — Diabetes — May 29th, 2026
Why metformin matters beyond diabetes: New target could reshape aging and cancer research
It turns out that metformin directly targets ATP5I, a small subunit of the enzyme that produces adenosine triphosphate (ATP), the energy-carrying molecule found in the cells of all living things, the UdeM researchers have found.
May 29th, 2026 — Source
Health — Diabetes — May 21st, 2026
Elevated blood glucose during pregnancy signals a significantly higher future diabetic risk
Gestational diabetes is a strong risk factor for future type 2 diabetes, even in women with normal pre-pregnancy weight, according to a study at the University of Gothenburg. The researchers call for earlier testing and better follow-up.
May 21st, 2026 — Source
Gestational diabetes increases risk of type 2 diabetes—even at normal weight
Gestational diabetes is a special type of diabetes that can affect pregnant women. The condition is defined as elevated blood sugar levels, without previously known diabetes. Treatment involves self-monitoring of blood sugar, advice on lifestyle habits and, if necessary, medication. Identifying gestational diabetes is important because the disease increases the risk of complications such as preeclampsia, the need for a cesarean section and high birth weight for the baby.
May 21st, 2026 — Source
Glucose Tracking Is Turning Into the Next Big Health Data Platform
Glucose tracking is moving beyond diabetes care as CGMs, AI platforms, and wearable sensors reshape personalized health data and wellness tools.
May 21st, 2026 — Source
HonorHealth Research Institute tests steam therapy for diabetes treatment
HonorHealth Research Institute is looking to become the first research facility in the nation to begin a new clinical trial that aims to modify the lining of the digestive tract with the use of steam energy to control type II diabetes without the use of drugs.
May 21st, 2026 — Source
Health — Diabetes — May 18th, 2026
A protective gel for a future without insulin injections
Researchers from the University of Geneva (UNIGE) and Geneva University Hospitals (HUG) have reached a significant advance in the fight against type 1 diabetes. Using an innovative hydrogel that supports insulin-producing cells once transplanted into the body, the team successfully regulated blood sugar levels in diabetic mice. This experimental success goes beyond conventional transplantation methods and opens the door to developing a bioartificial pancreas that could eliminate the need for insulin injections
May 18th, 2026 — Source
Researchers discover new clues to delaying type 1 diabetes
Thomas Delong, Ph.D., moved to Colorado from Germany two decades ago intent on one thing: understanding the origin of type 1 diabetes (T1D) and finding ways to stop it. Diagnosed at age 12 with the disease that affects 9.5 million people worldwide, Delong's mission was deep-rooted and personal.
May 18th, 2026 — Source
Health — Diabetes — May 14th, 2026
Real-time diagnostic smart dressing patch could end fear of diabetic foot amputation
Diabetic ulcers, which occur in patients with diabetes, are dangerous complications that can lead to amputation if the treatment window is missed. A research team has developed a wireless, battery-free optoelectronic multi-modal sensor patch for diabetic ulcer management. It can monitor wound conditions in real time.
May 14th, 2026 — Source
Semaglutide cuts BMI by 19% in treatment-resistant young adults with severe obesity, finds trial
A weekly dose of semaglutide (2.4 mg) leads to a clinically significant reduction in body mass index (BMI) and related health outcomes in young adults with severe obesity who are treatment resistant following hospital-based non-pharmacological obesity care during childhood, according to a randomized controlled trial being presented at the European Congress on Obesity (ECO26) in Istanbul, Turkey (12--15 May).
May 14th, 2026 — Source
Smart technology meets wound care to combat dangerous diabetic ulcers
"Diabetic ulcers," which occur in patients with diabetes, are dangerous complications that can lead to amputation if the treatment window is missed. A joint research team has developed a "smart dressing patch" that can monitor wound conditions in real time.
May 14th, 2026 — Source
Study shows that people who gain the most weight are at more than double the risk of certain cancers
New research presented at the European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) shows that people who gain the highest amount of weight across adulthood are at greatly increased risk of certain obesity-related cancers. The study is by Associate Professor Anton Nilsson and Associate Professor Tanja Stocks, Department of Translational Medicine, Lund University, Malmö, Sweden, and colleagues
May 14th, 2026 — Source
Health — Diabetes — May 11th, 2026
Diabetes, weight-loss drugs not a perfect fit?
Type 2 diabetes affects millions of people worldwide and now a new international study, jointly led by Adelaide University, University of Oxford, ETH Zurich, and Stanford University, has found one in ten people may not be benefiting from common medications used to treat the condition.
May 11th, 2026 — Source
Health — Diabetes — May 9th, 2026
Glucose nanoparticles help CBD cross the blood-brain barrier
Glucose-coated nanoparticles carry CBD across the blood-brain barrier, trigger release in inflamed tissue, and reduce neuroinflammatory signs in mice.
May 9th, 2026 — Source
Study shows benefits in obesity-linked conditions of losing more weight with GLP-1 treatment
New research presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12--15 May) shows that, following treatment for obesity or diabetes or both, using incretin-based drugs, losing more weight versus less weight, and losing a little weight versus gaining weight, both lead to a relatively lower risk of obesity-related conditions.
May 9th, 2026 — Source
Health — Diabetes — May 8th, 2026
AI-powered MRI scans predict diabetes and heart disease risk
Scientists developed an AI-powered MRI body composition calculator using data from over 66,000 adults, revealing how hidden changes in fat and muscle with age can signal future risks of diabetes, heart disease, and premature death.
May 8th, 2026 — Source
Metformin targets the gut instead of the liver to lower glucose
For decades, physicians and scientists thought metformin, the leading Type 2 diabetes medication taken by millions worldwide, mainly targets the liver to suppress glucose production. But a new Northwestern University study in mice has found this "wonder drug" instead focuses primarily on the gut, acting to prevent glucose levels rising in the blood by driving glucose utilization inside cells lining the intestine.
May 8th, 2026 — Source or Source
UK media portrays Type 1 and Type 2 diabetes stigma differently
Researchers analyzing nearly 10,000 U.K. news articles found that Type 1 diabetes is often portrayed through medical and biological narratives, whereas Type 2 diabetes coverage frequently emphasizes lifestyle and personal responsibility while overlooking broader social and economic factors that shape disease risk and management.
May 8th, 2026 — Source
Health — Diabetes — May 4th, 2026
Central nervous system a key player in diabetes pain
Changes within the central nervous system, including the brain and spinal cord, can be a key reason for pain in people with diabetes, and future treatments could focus on restoring the brain's pain blocking systems, according to new research.
May 4th, 2026 — Source
Health — Diabetes — April 27th, 2026
Cigarette exposure in the womb may amplify risk of metabolic disease in adulthood
People whose mothers smoked during pregnancy may benefit from paying extra attention to a healthy diet. According to a new study conducted in mice, the double-hit of maternal smoking and a high-fat, high-sugar diet during adulthood led to worse markers of metabolic health—such as higher body fat and higher cholesterol—than either factor alone. The results suggest that, in utero, cigarette exposure affects liver and fat tissue in ways that could contribute to obesity, fatty liver disease and other health problems.
April 27th, 2026 — Source
Health — Diabetes — April 24th, 2026
Epigenome map reveals how blood sugar-regulating cells change in type 2 diabetes
Researchers at Lund University in Sweden have carried out the most detailed mapping to date of the epigenome in the cells that regulate the body's blood sugar levels. The study, published in Nature Metabolism, shows how chemical changes to DNA affect both insulin-producing beta cells and glucagon-producing alpha cells—and how these patterns change in type 2 diabetes.
April 24th, 2026 — Source
Study identifies epigenetic patterns affecting insulin and glucagon production in type 2 diabetes
Researchers at Lund University in Sweden have carried out the most detailed mapping to date of the epigenome in the cells that regulate the body's blood sugar levels. The study, published in Nature Metabolism, shows how chemical changes to DNA affect both insulin-producing beta cells and glucagon-producing alpha cells -- and how these patterns change in type 2 diabetes.
April 24th, 2026 — Source
Sweet discovery rewrites understanding of how our bodies store sugar
WEHI researchers have discovered a never-before-seen mechanism our bodies use to regulate sugar, in findings that rewrite the fundamental rules of biology and open a new frontier in science. Published in Nature, the study is the first to uncover a potential therapeutic process that could be used to directly reduce the amount of sugar stored in the body. The paper is titled "Ubiquitination of glycogen and metabolites in cells and tissues."
April 24th, 2026 — Source
Health — Diabetes — April 23rd, 2026
3D DNA switch in brown fat could reshape obesity and diabetes treatment
Most fat stores energy; the body's brown fat does the opposite. Unlike the white fat that accumulates just under our skin, brown fat burns calories and glucose to generate heat. Formally known as brown adipose tissue, it is a specialized metabolic tissue whose importance in adults has only come into focus in recent years. Brown fat—stored in small, distinct pockets deep within the body—plays an outsized role in body-weight regulation and blood-sugar control, making it an attractive target for metabolic therapies.
April 23rd, 2026 — Source
Metabolic health may shape future dementia risk for Latino communities
Researchers from the University of California San Diego have found that diabetes is linked to changes in measurable biological signals in the blood that are associated with Alzheimer's disease and brain damage in Latino adults.
April 23rd, 2026 — Source or Source
Vitamin D may prevent diabetes in people with certain genes
More than two in five U.S. adults has prediabetes, a condition marked by higher-than-normal blood sugar levels that often leads to type 2 diabetes. A new study finds that vitamin D may help delay or prevent that progression, but only in people with certain genetic variations.
April 23rd, 2026 — Source
Health — Diabetes — April 21st, 2026
High-fat, low-carbohydrate diet may improve beta-cell function in patients with type 2 diabetes
People with type 2 diabetes on a high-fat, low-carbohydrate diet may have a better chance of reversing their diabetes than those on a low-fat diet, according to a small study published in the Journal of the Endocrine Society.
April 21st, 2026 — Source
Keto diet may improve beta cell function in people with type 2 diabetes
People with type 2 diabetes on a high-fat, low-carbohydrate diet may have a better chance of reversing their diabetes than those on a low-fat diet, according to a small study published in the Journal of the Endocrine Society.
April 21st, 2026 — Source
Health — Diabetes — April 13th, 2026
Genetic risk for type 1 diabetes extends to brain cells, study finds
Type 1 diabetes is an autoimmune condition in which the body attacks its own insulin-producing cells in the pancreas. Some individuals with type 1 diabetes experience cognitive differences, sometimes described as "brain fog," as well as memory lapses, which have often been attributed to fluctuations in blood sugar levels.
April 13th, 2026 — Source
Health — Diabetes — April 12th, 2026
Why Ozempic doesn't work for everyone: Scientists just found a hidden reason
A newly discovered genetic "GLP-1 resistance" may be why some people don't respond to Ozempic-like drugs at all.
April 12th, 2026 — Source
Health — Diabetes — April 11th, 2026
Genetic variants in 1 in 10 people may reduce blood‑sugar response to GLP‑1 diabetes drugs
More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might not work as well for people who have certain genetic variants, according to a new study by Stanford Medicine scientists and their collaborators.
April 11th, 2026 — Source
Health — Diabetes — April 9th, 2026
AI model links mental health to type 2 diabetes
A new study using an advanced "digital twin" artificial intelligence model has found that factors such as loneliness, insomnia and poor mental health substantially raise a person's future risk of developing type 2 diabetes. The research, led by Anglia Ruskin University (ARU) in collaboration with Cranfield University, the University of Portsmouth, and Intelligent Omics Ltd, and published in Frontiers in Digital Health, used lifestyle and health data from 19,774 UK adults in the UK Biobank, tracked for up to 17 years.
April 9th, 2026 — Source
Diabetes prevalence in American neighborhoods is influenced by historic and contemporary structural racism: Study
Diabetes is more prevalent in neighborhoods where historic residential redlining occurred and where contemporary structural racism persists, according to a new study by University at Buffalo population health researchers. Published on April 6 in JAMA Network Open, the research is the first study to examine diabetes prevalence in U.S. neighborhoods by taking into account direct and indirect associations of both historic redlining and contemporary structural racism.
April 9th, 2026 — Source
Overlooked non-coding genes cause diabetes in babies, study reveals
Scientists have found new genetic causes for diabetes in babies—in a part of the genome that has historically been overlooked in genetic studies. Until recently, most research has investigated causes of disease in "coding" genes—those that produce proteins. Now, academics at the University of Exeter and their international collaborators have found that DNA changes in two genes that instead make functional RNA molecules are a cause of diabetes. RNA plays various roles in the body, including regulating genes and influencing how genetic information is "read" and interpreted.
April 9th, 2026 — Source
The hidden tradeoff behind today's most popular weight loss drugs
Weight loss drugs and bariatric surgery may work differently, but they lead to surprisingly similar results inside the body. Both significantly reduce fat while also causing a modest loss of muscle, reshaping overall body composition. Since muscle helps protect against early death, this balance matters more than the number on the scale. The study suggests these treatments improve health—but not without trade-offs.
April 9th, 2026 — Source
Your brain can trick you into liking artificial sweeteners
What you think you're drinking may matter more than what's actually in your glass.
April 9th, 2026 — Source
Health — Diabetes — April 8th, 2026
Continuous glucose monitoring made me continuously crazy
MAHA is obsessed with these wearables — for all the wrong reasons.
April 8th, 2026 — Source
Glucose transport may hinge on a fleeting transition-like state
Stockholm University and SciLifeLab researchers have uncovered how glucose transporters move nutrients into cells, bridging a long-standing gap between structure and function in membrane biology. "Our study shows that these transport proteins rely on a previously uncharacterized intermediate state that functions much like the 'transition state' in enzyme catalysis. This is a discovery that reshapes our understanding of one of biology's most fundamental processes," says David Drew, professor of biochemistry, Department of Biochemistry and Biophysics, Stockholm University.
April 8th, 2026 — Source
Study finds genetic basis for GLP-1 weight loss efficacy and side effects
23andMe Research Institute, a nonprofit medical research organization, announced the publication of a study that identifies genetic predictors for GLP-1 weight loss efficacy and side effects.
April 8th, 2026 — Source
Tumor-inspired microparticles reprogram fat cells and improve insulin sensitivity
Mineral casts of cancer cell surfaces reprogram fat cells into stem cells and improve insulin sensitivity in obese mice through purely mechanical cues.
April 8th, 2026 — Source
Health — Diabetes — April 6th, 2026
Diabetes drug metformin may echo the benefits of exercise in prostate cancer care
A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise's core biological effects in men with prostate cancer, raising levels of a molecule tied to energy balance and weight control even when patients are inactive. The findings suggest that metformin could help counter the metabolic strain of hormone therapy, when fatigue and other side effects often limit physical activity.
April 6th, 2026 — Source
GLP-1 agonist drugs show digestive side effects but may help fight infections
Originally developed to treat diabetes, a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are now stepping into the spotlight as weight loss drugs. A recent umbrella review draws attention to safety concerns regarding the use of this GLP medication, alongside a mix of potential benefits.
April 6th, 2026 — Source
Health — Diabetes — April 1st, 2026
Fiber supplement stabilizes blood sugar in gestational diabetes
A simple fiber supplement could reshape the gut microbiome, stabilize blood sugar spikes, and even prevent preterm births in high-risk pregnancies, offering a promising new path for precision prenatal care.
April 1st, 2026 — Source
Health — Diabetes — March 31st, 2026
Lifestyle care in primary clinics allows for safe diabetes deprescribing
A new research study provides real-world evidence that deprescribing glucose‑lowering medications is both feasible and safe when patients with type 2 diabetes receive lifestyle‑informed care in primary care settings.
March 31st, 2026 — Source
Health — Diabetes — March 24th, 2026
Insulin pills may soon replace daily injections
For over a century, scientists have chased the dream of insulin pills, but the digestive system kept destroying the drug before it could work—forcing millions of patients to rely on daily injections. Now, researchers at Kumamoto University have developed a clever workaround using a tiny peptide that helps insulin slip through the intestinal wall.
March 24th, 2026 — Source
New algorithm can better manage type 2 diabetes, study finds
A University of Virginia Center for Diabetes Technology-developed algorithm—paired with a continuous glucose monitor—can help users better manage their type 2 diabetes by recommending insulin-dose adjustments, a new study found
March 24th, 2026 — Source
Widespread temptations bad news for people with a high risk of diabetes, says study
Type 2 diabetes is often triggered by a sedentary lifestyle or poor diet. At the same time, however, some people have genes that make it much more likely they will develop the disease. In other words, they are far more susceptible to developing diabetes.
March 24th, 2026 — Source
Health — Diabetes — March 22nd, 2026
Losing health insurance worsens diabetes outcomes in low-income adults
Losing health insurance can quickly worsen health for people with diabetes as patients struggle to control the disease after coverage is interrupted, according to new research from Oregon Health & Science University,
March 22nd, 2026 — Source
Health — Diabetes — March 20th, 2026
Diabetes outcomes worsen after insurance loss, study finds
Losing health insurance can quickly worsen health for people with diabetes as patients struggle to control the disease after coverage is interrupted, according to new research from Oregon Health & Science University.
March 20th, 2026 — Source
Having a primary care physician reduces emergency department use for patients on dialysis
Kunal Bailoor, M.D., from the University of Michigan in Ann Arbor, and colleagues examined whether having a primary care practitioner is associated with a lower risk for hospitalization and ED utilization among patients with end-stage kidney disease. The analysis included 181,520 Medicare Fee for Service beneficiaries receiving dialysis from 2018 through 2019.
March 20th, 2026 — Source
More sleep and physical activity may prevent Type 2 diabetes in teens
Adolescents who replaced just half an hour of sedentary behaviors, such as sitting on the couch or spending time at the computer, each day for moderate-to-vigorous physical activity or sleep may lower their insulin resistance, a key factor in preventing the development of Type 2 diabetes, according to preliminary research presented at the American Heart Association's EPI|Lifestyle Scientific Sessions 2026. The meeting is in Boston, March 17--20, 2026, and offers the latest epidemiological science on prevention, lifestyle and cardiometabolic health.
March 20th, 2026 — Source
Health — Diabetes — March 18th, 2026
Quitting Ozempic Could Hit Your Heart Hard, Study Finds
New research reaffirms that GLP-1s can help prevent heart attacks, but only as long as you're taking them.
March 18th, 2026 — Source
Stopping GLP-1 drugs can quickly erase cardiovascular benefits
Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular benefits. However, when patients stop taking these drugs, they not only regain weight, but, according to a new study, they also incur increased risk of heart attack, stroke, and death compared to staying on the medication.
March 18th, 2026 — Source
Health — Diabetes — March 16th, 2026
New genetic risk score better predicts diabetes, obesity and downstream complications
Type 2 diabetes (T2D) and obesity are metabolic conditions with many causes, including overlapping and distinct genetic features. A polygenic risk score (PRS) can capture multiple genetic risk factors to provide an estimate for whether a person may develop a complex medical condition and how they might fare long-term.
March 16th, 2026 — Source
Health — Diabetes — March 12th, 2026
Father's nicotine use may increase diabetes risk for offspring
An estimated 40.1 million people in the United States have diabetes, according to the U.S. Centers for Disease Control and Prevention. Having diabetes puts people at risk of developing other conditions like heart disease, kidney disease and nerve damage. Since diabetes affects more than 12 percent of Americans and is a chronic disease, the costs of treatment are high.
March 12, 2026 — Source
Health — Diabetes — March 5th, 2026
Combination therapy reduces effects of 'zombie cells' in diabetic kidney disease, research finds
Mayo Clinic researchers have identified a drug-and-supplement combination therapy that is capable of reducing the harmful effects of senescent cells—also known as "zombie cells"—in diabetic kidney disease. In eBioMedicine, the team reported that the combination of the cancer drug dasatinib and a naturally occurring substance known as quercetin decreased inflammation and boosted protective factors in the kidney.
March 5, 2026 — Source
Nanoparticle system shows promise for delivering mRNA to prevent Type 1 diabetes
Lipid nanoparticles deliver mRNA to insulin-producing beta cells, prompting them to express a protective protein that shields them from autoimmune attack.
March 5, 2026 — Source
Research reveals challenges of living with gestational diabetes
A study from the University of Limerick in Ireland has identified the hidden challenges of women living with and managing Gestational Diabetes Mellitus (GDM). The research led by academics in UL's Department of Psychology is the first review of the evidence in this area. It highlights specifically how partners influence the experiences of women diagnosed with GDM.
March 5, 2026 — Source
Study identifies the hidden challenges of women with gestational diabetes
A study from University of Limerick in Ireland has identified the hidden challenges of women living with and managing Gestational Diabetes Mellitus (GDM).
March 5, 2026 — Source
What to know about how GLP-1 medications might fight addiction
The blockbuster GLP-1 drugs that have reshaped the treatment of diabetes and obesity may help prevent multiple substance use disorders—and reduce the tragic outcomes they cause, a large new study finds.
March 5, 2026 — Source
Health — Diabetes — March 3rd, 2026
Diabetes and liver medications failed to treat long COVID
The search for long COVID treatments continues, as a randomized clinical trial found that a two-week course of metformin or ursodeoxycholic acid (UDCA) did not meaningfully improve recovery from symptoms, despite earlier evidence suggesting metformin could lower long-term risk when taken during acute infection. The findings underscore the continued lack of proven treatments to alleviate symptoms of long COVID.
March 3, 2026 — Source
GLP-1 drugs may cut risk of major heart complications after heart attack
Weight-loss (GLP-1 mimicking) drugs may help prevent further tissue damage following a heart attack, significantly reducing the risk of further life-threatening complications that affect up to half of all patients, according to a new study led by the University of Bristol and University College London (UCL).
March 3, 2026 — Source
Glucose drives STAT3 activation in colorectal cancer cells, leading to tumor growth
Colorectal cancer is the third most common cancer in the United States. Although screening has led to a decrease in incidence over the past 20 years, early-onset colorectal cancer has been rising. Despite advances in surgery and therapies, patients with metastatic colorectal cancer continue to have poor outcomes, highlighting the need for novel treatments.
March 4, 2026 — Source
Health — Diabetes — March 2nd, 2026
A bold new plan could finally cure type 1 diabetes
A daring new therapy aims to cure type 1 diabetes by rebuilding insulin cells — and training the immune system to protect them.
March 2, 2026 — Source
Health — Diabetes — February 17th, 2026
Huawei's Smartwatch Adds Needle-Free Diabetes Risk Monitoring
Huawei introduces a diabetes risk assessment feature on the Watch GT 6 Pro, offering needle-free early detection of risk through advanced wearable sensors.
February 17, 2026 — Source
Health — Diabetes — February 15th, 2026
Will Ozempic-style patches help you lose weight? Two experts explain
Could a simple patch, inspired by the weight-loss drug Ozempic, really help you shed excess kilos without the pain and effort of an injection?
February 15, 2026 — Source
Health — Diabetes — February 14th, 2026
Combining GLP-1 drugs with hormones may lower uterine cancer risk
Adding GLP-1 medications like Ozempic to progestin therapy could cut the risk of developing endometrial cancer. A retrospective study published in the journal JAMA Network Open found that women using this combination had a much lower risk of developing the disease than those on progestins alone.
February 14, 2026 — Source
Health — Diabetes — February 13th, 2026
Inactivity linked to up to 10% of type 2 diabetes complications
A lack of exercise drives a good portion of the health problems faced by people with type 2 diabetes, a new study says.
February 13, 2026 — Source
Health — Diabetes — February 12th, 2026
Boosting good immune cells can help fight insulin resistance and diabetes
Scientists at the University of Pittsburgh School of Medicine discovered a surprising new way the body can fight insulin resistance and diabetes -- by boosting a special type of "good" immune cell in fat tissue.
February 12, 2026 — Source
Sleep‑aligned fasting improves key heart and blood‑sugar markers
A new Northwestern Medicine study has personalized overnight fasting by aligning it with individuals' circadian sleep-wake rhythm—an important regulator of cardiovascular and metabolic function—without changing their caloric intake.
February 12, 2026 — Source
Why visceral fat triggers diabetes: Study points to loss of protective macrophages
Scientists at the University of Pittsburgh School of Medicine discovered a surprising new way the body can fight insulin resistance and diabetes—by boosting a special type of "good" immune cell in fat tissue.
February 12, 2026 — Source
Health — Diabetes — February 11th, 2026
Posture-induced retinal vascular response predicts diabetic retinopathy progression
Diabetic retinopathy develops through complex microvascular damage driven by chronic hyperglycemia, yet traditional risk factors such as disease duration or glycemic control explain only part of individual risk. The retina offers a unique, non-invasive view of microvascular health, where early functional abnormalities may appear before visible retinal lesions. Under normal conditions, retinal vessels automatically constrict or dilate to maintain stable blood flow when body position changes. In diabetes, this autoregulatory capacity is often impaired, reflecting endothelial and neurovascular dysfunction.
February 11, 2026 — Source
Wearable biosensor could improve wireless glucose monitoring for people with diabetes
A wearable biosensor developed by Washington State University researchers could improve wireless glucose monitoring for people with diabetes, making it more cost-effective, accurate, and less invasive than current models.
February 11, 2026 — Source
Health — Diabetes — February 6th, 2026
A "living" artificial pancreas implant could be a breakthrough for people with diabetes
Powered by protective crystal structures, the cell-based device could one day make daily insulin injections obsolete
February 6, 2026 — Source
Health — Diabetes — February 4th, 2026
Expert-Approved Continuous Glucose Monitors to Track Your Glucose Daily
If you're tracking your glucose, these are the best monitors, according to the pros.
February 4, 2026 — Source
Implantable immune scaffold predicts type 1 diabetes weeks before symptoms
A retrievable immune scaffold reveals a 5--7 week presymptomatic window for tracking type 1 diabetes progression, long before blood sugar tests turn positive.
February 4, 2026 — Source
Health — Diabetes — January 19th, 2026
Dual closed-loop insulin system adds chemical safeguard to protect against dangerous overdoses
A wearable device pairs glucose-responsive insulin with algorithmic pump control, creating dual safety loops that reduced hypoglycemia from 4.01% to 0.52% in diabetic rats.
January 19, 2026 — Source
People with mental illness found to receive poorer diabetes care
People with mental illness have a higher risk of developing diabetes due to multiple factors. However, they do not receive adequate medical care for existing diabetes, as an international study led by the Medical Faculty of the University of Augsburg now shows.
January 19, 2026 — Source
PFAS exposure increases gestational diabetes risk
A comprehensive review of nearly 130 studies shows the strongest evidence to date that "forever chemicals" are associated with gestational diabetes, while underscoring uncertainty around other diabetes outcomes and the need for more prospective research.
January 19, 2026 — Source
Health — Diabetes — January 9th, 2026
A better way to sell premade food could cut waste and boost sales
Grocery stores typically place older products in front. New research suggests the opposite approach actually works best.
January 9, 2026 — Source
Diabetes costs the global economy trillions, says study
Diabetes mellitus is a chronic metabolic disorder and one of the most prevalent non-communicable diseases worldwide. On average, one in ten adults is affected. The number of people living with diabetes continues to rise, posing an increasing challenge for health care systems and entire economies. A new study reveals the global and national economic costs of diabetes and offers strategies to reduce them.
January 9, 2026 — Source
Long-term diabetes changes red blood cells, increasing cardiovascular disease risk
The longer a person has type 2 diabetes, the greater the risk of cardiovascular disease. A new study from Karolinska Institutet, published in the journal Diabetes, shows that changes in red blood cells may be an important explanation, and identifies a specific molecule as a possible biomarker.
January 9, 2026 — Source
Pancreatic organoid study reveals key factors shaping complex lumen formation
Organs often have fluid-filled spaces called lumens, which are crucial for organ function and serve as transport and delivery networks. Lumens in the pancreas form a complex ductal system, and its channels transport digestive enzymes to the small intestine. Understanding how this system forms in embryonic development is essential, both for normal organ formation and for diagnosing and treating pancreatic disorders.
January 9, 2026 — Source
Red blood cell changes may explain link between long-term diabetes and vascular damage
The longer a person has type 2 diabetes, the greater the risk of cardiovascular disease. A new study from Karolinska Institutet, published in the journal Diabetes, shows that changes in red blood cells may be an important explanation, and identifies a specific molecule as a possible biomarker.
January 9, 2026 — Source
Research shows benefits of lifestyle interventions in reducing the risk of gestational diabetes
New research co-authored by Professor Fionnuala McAuliffe, UCD School of Medicine, and led by the University of Liverpool, has demonstrated the significant benefits of lifestyle interventions in reducing the risk of gestational diabetes.
January 9, 2026 — Source
Study reveals the global economic costs of diabetes
Diabetes mellitus is a chronic metabolic disorder and one of the most prevalent non-communicable diseases worldwide. On average, one in ten adults is affected. The number of people living with diabetes continues to rise, posing an increasing challenge for healthcare systems and entire economies. A new study reveals the global and national economic costs of diabetes and offers strategies to reduce them.
January 9, 2026 — Source
Health — Diabetes — January 8th, 2026
Apple Watch blood sugar monitoring a step closer as new tech launches
Apple Watch blood sugar monitoring is something the company reportedly wanted to do right from the start. A report back in 2023 said that the very first Apple Watch was initially intended to launch with non-invasive glucose measurement as a headline feature.
January 8, 2026 — Source
Mapping proteins in African genomes reveals new paths to fight type 2 diabetes
Researchers have conducted the most comprehensive analysis to date linking plasma proteins to genetic variation in individuals from continental Africa. Their study addresses a long-standing gap by studying a population grossly underrepresented in medical research. The findings could pave the way for earlier and more accurate type 2 diabetes diagnoses, as well as treatments tailored to African populations.
January 8, 2026 — Source
Health — Diabetes — January 7th, 2026
A fresh energy supply may shield nerves from diabetic or chemo-induced neuropathy
Researchers demonstrate that transferring healthy mitochondria from support glial cells to nerve cells could reduce nerve pain and degeneration.
January 7, 2026 — Source
Higher intake of food preservatives linked to increased risk of type 2 diabetes
Higher consumption of food preservatives, widely used in industrially processed foods and beverages to extend their shelf life, has been linked to an increased risk of type 2 diabetes. These findings are the result of work carried out by researchers from Inserm, INRAE, Sorbonne Paris Nord University, Paris Cite University and Cnam, within the Nutritional Epidemiology Research Team (CRESS-EREN). They are based on health and dietary data from more than 100,000 adults participating in the NutriNet-Sante cohort study, and published in the journal Nature Communications.
January 7, 2026 — Source
If You Have Diabetes, Libre Assist Uses AI to Predict Your Meal's Glucose Level
Simply snap a photo of your food to learn how it may impact your blood sugar levels.
January 7, 2026 — Source
Lifestyle interventions in pregnancy proven to reduce gestational diabetes risk
Researchers at the University of Liverpool have led the largest study to date demonstrating the significant benefits of lifestyle interventions in reducing the risk of gestational diabetes.
January 7, 2026 — Source
Movement matters: Light activity may lead to better survival in diabetes, heart, kidney disease
Nearly 90% of U.S. adults have at least one component of CKM syndrome, which includes high blood pressure, abnormal cholesterol and lipids, high blood glucose (sugar), excess weight and reduced kidney function. When combined, these factors increase the risk for heart attack, stroke and heart failure more than any one of them alone. CKM stages range from 0 to 4, with the higher number indicating higher risk for heart disease and stroke.
January 7, 2026 — Source
Newly discovered gut microbial molecules in infancy may influence the risk of type 1 diabetes
An international research team has uncovered compelling evidence that gut-microbe-derived molecules may play an important role in shaping the developing immune system during early childhood.
January 7, 2026 — Source
Study shows beneficial impact of natural light on people with type 2 diabetes
Metabolic diseases have reached epidemic proportions in our society, driven by a sedentary lifestyle coupled with circadian misalignment - a desynchrony between our intrinsic biological clocks and environmental signals. Furthermore, we spend almost 90% of our time indoors, with a very limited exposure to natural daylight. To investigate the specific role of daylight in human metabolism, particularly in glycemic control, researchers from the University of Geneva (UNIGE), the University Hospitals of Geneva (HUG), Maastricht University, and the German Diabetes Center (DDZ) conducted a controlled study with thirteen volunteers with type 2 diabetes.
January 7, 2026 — Source
Health — Diabetes — January 6th, 2026
Novo Nordisk launches daily weight-loss pill to expand GLP-1 access
On Monday, Novo Nordisk rolled out the first GLP-1 weight-loss pill, an oral version of Wegovy.
January 6, 2026 — Source
Semaglutide improves knee replacements for patients with diabetes
For those with type 2 diabetes who have knee osteoarthritis, getting a knee replacement can be difficult because they are more likely to have surgical complications.
January 6, 2026 — Source
You can track your glucose levels in the Withings app now - here's how
At CES 2026, Withings partnered with Abbott to offer continuous glucose monitoring.
January 6, 2026 — Source
Health — Diabetes — January 5th, 2026
If You Have Diabetes, Libre Assist Uses AI to Predict Your Meal's Glucose Level
Simply snap a photo of your food to learn how it may impact your blood sugar levels.
January 5, 2026 — Source
PreEvnt's isaac Non-Invasive Glucose Alert System Enters Human Trials
PreEvnt's isaac system is getting closer to its targeted Q4 2026 launch. It has gone from a concept prototype to active human clinical trials. The device uses VOC-sensing technology to check glucose biomarkers in exhaled breath. This is a non-invasive way to keep track of metabolic health. Isaac is currently being tested for FDA approval to help people with Type 2 diabetes and prediabetes. It has an app that sends real-time alerts and reports that doctors can share.
January 5, 2026 — Source
SGLT-2 inhibitors linked to lower risk of diabetic foot nerve damage
A large population-based study found that adults with type 2 diabetes (T2D) who start treatment with sodium--glucose cotransporter-2 (SGLT-2) inhibitors have a slightly lower risk of developing diabetic foot problems compared to those taking glucagon-like peptide-1 (GLP-1) receptor agonists.
January 5, 2026 — Source
Health — Diabetes — January 2nd, 2026
Increase in food prices can lead to stunted growth in children
We're throwing away food that's actually still good to eat.
January 2, 2026 — Source
Health — Diabetes — December 21st, 2025
Expert-Approved Continuous Glucose Monitors for Easy Tracking
If you're interested in trying out one of these monitors, start with these top picks.
December 21, 2025 — Source
How natural daylight can help people with diabetes improve blood sugar levels
People with type 2 diabetes may be able to improve their blood sugar by doing something as simple as sitting by a window for a few hours each day. In a study published in Cell Metabolism, scientists showed that natural daylight helps maintain healthy glucose levels.
December 21, 2025 — Source
Health — Diabetes — December 19th, 2025
Key protein ACE2 could protect against high blood pressure and diabetes
Proteins circulating in the blood can reveal what's happening in the body, from how we process energy to how diseases develop. Unlike genetic testing, which shows fixed risk factors from birth, protein analysis provides a real‐time picture of health and disease.
December 19, 2025 — Source
Health — Diabetes — December 15th, 2025
3 Surprising Things I Learned While Using an AI-Powered Glucose Monitor for 2 Weeks
Your dailly habits also impact your blood sugar. Here's what to know.
December 15, 2025 — Source
Health — Diabetes — December 12th, 2025
Nanozyme Hydrogel Directly Targets Cause of Diabetic Osteoarthritis
Researchers have developed a nanozyme-integrated hydrogel that directly targets advanced glycation end products (AGEs), a key driver of diabetic osteoarthritis (DOA).
December 12, 2025 — Source
Health — Diabetes — December 5th, 2025
PFAS exposure may limit improvements in blood sugar after bariatric surgery
A new USC study shows teens with higher blood levels of per- and polyfluoroalkyl substances (PFAS) measured before bariatric surgery had smaller improvements in blood sugar over five years, including fasting glucose and hemoglobin A1c (HbA1c), which measures average blood sugar levels over the past 60--90 days.
December 5, 2025 — Source
Health — Diabetes — December 3rd, 2025
Diabetes drugs may help older adults slow frailty
A new study shows that older adults with type 2 diabetes who start treatment with sodium--glucose cotransporter-2 (SGLT-2) inhibitors—such as empagliflozin (Jardiance) and dapagliflozin (Farxiga)—or glucagon-like peptide-1 (GLP-1) receptor agonists—such as semaglutide (Ozempic) and liraglutide (Victoza)—experience slower progression of frailty over one year compared with those starting other diabetes medications.
December 3, 2025 — Source
How diabetes affects your eyes
While eye care and regular eye exams are important for everyone, they're particularly vital for people with diabetes.
December 3, 2025 — Source
How mouth health affects diabetes, and vice versa
Imagine trying to enjoy your favorite meal but finding that your gums hurt, your mouth feels dry and chewing has become uncomfortable. For people living with diabetes, this can be a daily reality that often goes unrecognized.
December 3, 2025 — Source
Noninvasive blood-glucose monitoring method could replace finger-prick tests for diabetes
A noninvasive method for measuring blood glucose levels, developed at MIT, could save diabetes patients from having to prick their fingers several times a day.
December 3, 2025 — Source or Source
Health — Diabetes — November 26th, 2025
Finerenone shows superior survival and kidney protection over spironolactone in diabetic kidney disease
Finerenone shows superior survival and kidney protection over spironolactone in diabetic kidney disease
November 23, 2025 — Source
Possible therapeutic approach to treat diabetic nerve damage discovered
Nerve damage is one of the most common and burdensome complications of diabetes. Millions of patients worldwide suffer from pain, numbness, and restricted movement, largely because damaged nerve fibers do not regenerate sufficiently. The reasons for this are unclear.
November 23, 2025 — Source
Regenerative medicine offers a pathway toward curing type 1 diabetes
Type 1 diabetes (T1D) is an autoimmune disorder characterized by the specific destruction of insulin-producing pancreatic &beta-cells. While islet transplantation has demonstrated promise, its widespread application is hampered by immune rejection, the necessity for lifelong immunosuppression, and a critical shortage of donor organs. This review posits that regenerative medicine, particularly strategies centered on stem cells and pancreatic progenitor cells, holds the key to a lasting cure.
November 23, 2025 — Source
Stanford's new cell therapy cures type 1 diabetes in mice
Researchers at Stanford found a way to cure or prevent Type 1 diabetes in mice using a combined blood stem cell and islet cell transplant. The procedure creates a hybrid immune system that stops autoimmune attacks and eliminates the need for immune-suppressing drugs. The method uses tools already common in clinical practice, putting human trials within reach. Scientists think the same strategy could transform treatments for autoimmune conditions and organ transplantation.
November 23, 2025 — Source
Health — Diabetes — November 21st, 2025
Chemerin receptor structures disclose new mechanism of lipid metabolism
Chemerin is a key adipokine that regulates lipid metabolism and insulin sensitivity, and thus is involved in many metabolic diseases such as obesity and diabetes. In addition, it plays a critical role in inflammation as a chemoattractant adipokine by guiding immune cell trafficking to inflammatory sites.
November 21, 2025 — Source
Hidden immune cells linked to early type 1 diabetes detected in lymph nodes
Type 1 diabetes (T1D) impacts nearly two million Americans, and by the time most people learn they have it, most of the body's insulin-producing cells are destroyed. Now, pinpointing a hidden group of immune "attack" cells in the pancreatic lymph nodes that appear earlier in the disease could offer the first real chance to detect—and even stop—T1D, according to new research from the Perelman School of Medicine at the University of Pennsylvania detailed in Science Immunology.
November 21, 2025 — Source
People with diabetes or fatty liver disease found less effective at obtaining energy from ketone bodies
The liver plays a central role in storing and supplying energy to the body. In type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD, commonly referred to as fatty liver disease), mitochondria—the cell's power plants—cannot switch efficiently between fuel sources.
November 21, 2025 — Source
Health — Diabetes — November 20th, 2025
Study suggests type 1 diabetes may significantly raise bladder cancer risk
People with type 1 diabetes (previously called juvenile diabetes) are 4.29 times more likely to develop bladder cancer, according to a systematic review and meta-analysis by researchers at the Keck School of Medicine of USC. The new analysis is the first to control for the effects of tobacco smoking, a factor that likely obscured the heightened risk in earlier studies.
November 20, 2025 — Source
Health — Diabetes — November 14th, 2025
Study shows Ozempic could help dialysis patients qualify for kidney transplants
Obesity is one of the biggest barriers preventing patients with end-stage kidney disease from receiving a life-saving kidney transplant. New research from Saint Louis University School of Medicine and SSM Health physicians reveals that breakthrough weight loss medications could change that—giving more patients a second chance at life.
November 14, 2025 — Source
Health — Diabetes — November 13th, 2025
New study finds hidden diabetes danger in vaping
Vaping and smoking may be fueling a hidden surge in metabolic disease.
November 13, 2025 — Source
Why type 1 diabetes is more aggressive in young children
Scientists have made a major breakthrough in understanding why type 1 diabetes is more aggressive in young children, offering the clearest explanation to date of why the condition is particularly difficult to manage when diagnosed early in life.
November 13, 2025 — Source or Watch Video
Health — Diabetes — November 7th, 2025
Diabetes drug blunts exercise-induced health improvements
A widely prescribed diabetes drug may be sabotaging one of the most trusted strategies for preventing the disease: exercise.
November 7, 2025 — Source
Insulin rationing persists despite policy changes, study shows
For those with type 1 diabetes, insulin is necessary for survival, explains Yale School of Medicine's Kasia Lipska, MD, MHS, the study's corresponding author. Insulin is also essential for many individuals with type 2 diabetes, who use it to control their blood sugars. The medicine, which was discovered more than 100 years ago, should be available, accessible, and affordable for all those with diabetes, Lipska says.
November 7, 2025 — Source
More Americans are on dialysis. Could more safely wean off it?
Weaning patients with acute kidney injury (AKI) from dialysis while they are still hospitalized may save them from remaining on the treatment for the rest of their lives, according to a new study led by UC San Francisco.
November 7, 2025 — Source
Health — Diabetes — November 6th, 2025
Finerenone reduces kidney damage in type 1 diabetes by lowering protein in urine
The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the amount of proteins excreted in the urine of these patients. This reduction indicates that the degree of kidney damage is reduced and that the drug has a protective effect on kidney function.
November 6, 2025 — Source
Maternal type 1 diabetes may protect children through epigenetic changes
Type 1 diabetes is an autoimmune disease in which the immune system destroys the body's own insulin-producing beta-cells in the pancreas, leaving patients with a lifelong dependency on external insulin.
November 6, 2025 — Source
Health — Diabetes — October 30th, 2025
New model shows how treating diabetes early makes a difference
Could slightly elevated blood sugar levels lead to serious health problems in the future? A single patient's question sparked nearly a decade of research leading to the development of a landmark model that could shape how clinicians and researchers understand and manage diabetes across the US.
October 30, 2025 — Source
Researcher provides new hope in managing diabetic ketoacidosis
A researcher at the University of Houston finds management of diabetic ketoacidosis may center around reducing ketone levels in diabetic patients and increasing exercise capacity for better health outcomes. That could be life-changing for approximately 20%--30% of the 830 million diabetic patients who develop ketoacidosis, which occurs when there are too many ketones in the blood, and is life-threatening if left untreated.
October 30, 2025 — Source
Health — Diabetes — October 24th, 2025
Bariatric surgery in a pill bottle
More than 37 million Americans have type 2 diabetes, a chronic disorder affecting the body's ability to regulate and use sugar. According to the CDC, it's the country's seventh leading cause of death. Type 2 diabetes can be treated with lifestyle changes and medications, including insulin, a sugar-regulating hormone.
October 24, 2025 — Source
Best Continuous Glucose Monitors, According to Experts
These monitors can connect to your phone or smartwatch for easy tracking.
October 24, 2025 — Source
Health — Diabetes — October 20th, 2025
California to launch insulin for just $11 a pen
California will start selling low-cost insulin on Jan. 1, nearly three years after Gov. Gavin Newsom announced a plan to make lifesaving medications more affordable for folks with diabetes.
October 20, 2025 — Source
Mortality down with GLP-1 receptor agonist use in T2D, especially in those with OSA
Patients with type 2 diabetes mellitus (T2DM) prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have significantly lower one-year mortality, especially those also diagnosed with obstructive sleep apnea (OSA), according to a study presented at CHEST 2025, the annual meeting of the American College of Chest Physicians, held from Oct. 19 to 22 in Chicago.
October 20, 2025 — Source
Physical activity linked to higher overnight glucose in pregnancy hyperglycemia
A new study using continuous glucose monitors and wearable trackers uncovers a surprising twist in pregnancy health. This shows that more daily movement could mean higher overnight blood sugar, challenging assumptions about exercise and glucose control.
October 20, 2025 — Source
Health — Diabetes — October 17th, 2025
Assessing future physicians' awareness of diabetes stigma in health care
Assessing future physicians' awareness of diabetes stigma in health care
October 17, 2025 — Source
Health — Diabetes — October 15th, 2025
GLP-1 drugs may delay alcohol's effects in the bloodstream
GLP-1 agonists, including semaglutide, tirzepatide, and liraglutide, slow the rate at which alcohol enters the bloodstream, resulting in a slower rise in breath alcohol concentration and reduced subjective intoxication. This effect is likely due to delayed gastric emptying. These findings suggest GLP-1 drugs may help reduce alcohol consumption through a mechanism distinct from existing treatments.
October 15, 2025 — Source
Strong grip strength may protect against obesity-related complications
Higher grip strength in individuals with excess body fat is associated with a reduced risk of developing obesity-related organ dysfunction and lower mortality over time. Grip strength, as a measure of muscle strength, consistently correlates with better outcomes, suggesting that maintaining muscle may help protect against complications linked to obesity.
October 15, 2025 — Source
Type 1 diabetes increased among young people during the pandemic
During the COVID-19 pandemic, Sweden saw a temporary increase in type 1 diabetes cases among people under 30, especially children under 5 and young adult men, with cases rising by 12% in 2021 and 9% in 2022. COVID-19 infection was linked to accelerated onset only in children aged 5--9. Lifestyle changes during the pandemic may have contributed, while vaccination was not a factor.
October 15, 2025 — Source
Health — Diabetes — October 8th, 2025
Depression during pregnancy raises risk of gestational diabetes
Researchers uncover a consistent global link between antenatal depression and gestational diabetes, highlighting how early emotional support and screening could protect both maternal and newborn health.
October 8, 2025 — Source
Health — Diabetes — October 3rd, 2025
Diabetes drugs show promise for treatment of alcohol use disorder
Genetic analyses indicate that variants in GLP1R and GIPR, targets of diabetes drugs, are associated with reduced alcohol consumption and improved liver health, without affecting use of tobacco, cannabis, or opioids. These findings suggest that GLP-1 and GIP-based therapies may help treat alcohol use disorder by influencing metabolic and appetite regulation pathways.
October 3, 2025 — Source
Health — Diabetes — September 29th, 2025
AI body composition measurements can predict cardiometabolic risk
Adiposity—or the accumulation of excess fat in the body—is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease. But getting the full picture of a person's risk is harder than it may seem. Traditional measures such as body mass index (BMI) are imperfect, conflating fat and muscle mass and not capturing where in the body fat is located.
September 29, 2025 — Source
Zika virus may raise long-term risks of type 2 diabetes
Zika virus can infect the hypothalamus in the adult brain, causing inflammation and persistent insulin resistance even after recovery from the initial infection. This disruption in insulin signaling may increase the long-term risk of developing type 2 diabetes, highlighting the need to monitor metabolic health in individuals previously infected with Zika.
September 29, 2025 — Source
Health — Diabetes — September 26th, 2025
Weight loss treatments for people with diabetes and obesity could lower the risk of obesity-related cancers
Weight loss treatments, including medication and surgical procedures, may help lower the risk of obesity-related cancers in people with obesity and type 2 diabetes, a new study shows.
September 26, 2025 — Source
Health — Diabetes — September 25th, 2025
Cruciferous vegetables beat root vegetables in stabilizing blood sugar
A two-week trial reveals that soups made from broccoli, cabbage, and kale reduce post-meal glucose spikes more effectively than starchy vegetables like potatoes and pumpkin, pointing to the unique power of cruciferous vegetables for metabolic health.
September 25, 2025 — Source
This high-sugar fruit may actually lower diabetes risk
Mangos beat low-sugar snacks in a study, improving blood sugar and body fat in prediabetics.
September 25, 2025 — Source
Health — Diabetes — September 22nd, 2025
Arts programs can help prevent heart disease, diabetes and other leading causes of death, large study finds
Art isn't just for stages and studios. It can be a powerful public health resource. That's the takeaway from a new international study, commissioned by the Jameel Arts and Health Lab, that examined nearly 100 research projects from 27 countries to consider how arts programs, such as music, dance, theater, storytelling and other creative and cultural activities, can help prevent some of the world's biggest killers: heart disease, diabetes, cancer, and other non-communicable diseases, which account for 74% of preventable deaths worldwide.
September 22, 2025 — Source
Cruciferous vegetables aid in regulation of blood sugar levels
New research from Edith Cowan University (ECU) published in Diabetes, Obesity and Metabolism has found evidence that cruciferous vegetables like broccoli and kale could help with the management of blood sugar levels, particularly for people at risk of type 2 diabetes and cardiovascular disease (CVD).
September 22, 2025 — Source
Want a younger brain? Harvard researchers say eat like this
Researchers have shown that a green-Mediterranean diet can help slow brain aging. By analyzing data from the DIRECT PLUS trial, scientists found reduced levels of proteins tied to faster brain decline among those consuming green tea and Mankai. The results point to anti-inflammatory compounds as key protectors of brain health. This diet may be a powerful tool for preserving cognitive function.
September 22, 2025 — Source
Health — Diabetes — September 19th, 2025
Alpha cells moonlight as secret GLP-1 factories: Hormone shift could transform type 2 diabetes treatment
A new study from Duke University School of Medicine is challenging long-standing views on blood sugar regulation—and pointing to a surprising new ally in the fight against type 2 diabetes.
September 19, 2025 — Source
Health — Diabetes — September 16th, 2025
New drug could be first to stop deadly fatty liver disease
New investigational treatment interrupts disease at its source, offering hope for millions with life-threatening liver condition linked to obesity and diabetes.
September 16, 2025 — Source
Health — Diabetes — September 9th, 2025
Bariatric surgery for weight loss shows greater long-term benefits than GLP-1 medicines
A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live longer and face fewer serious health problems compared with those treated with GLP-1 receptor agonist medicines alone.
September 16, 2025 — Source
CPAP treatment may reduce death risk in people with both type 2 diabetes and sleep apnea
People with both type 2 diabetes (T2D) and obstructive sleep apnea have a higher risk of death, but treatment with continuous positive airway pressure (CPAP) may reduce that risk by around 26%, according to new research being presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Vienna (15-19 Sept).
September 9, 2025 — Source
Diabetes remains undiagnosed and untreated among a large portion of the global population
A large portion of the global population with diabetes remains undiagnosed or is not receiving optimal care, according to a new study published in The Lancet Diabetes & Endocrinology. The Institute for Health Metrics and Evaluation (IHME) at the University of Washington School of Medicine and a global network of collaborators conducted the analysis of the diabetes care cascade for all ages, both sexes, and 204 countries and territories from 2000 to 2023.
September 9, 2025 — Source
Genomic and hormone study finds 22 additional type 2 diabetes-related variants
Type 2 diabetes affects an increasing number of people worldwide, and more often affects men than women. The disease is caused by a mix of genetic and lifestyle factors, but little is known about how someone's environment—both inside and outside the body—interacts with their genes to impact a person's risk of developing the disease.
September 9, 2025 — Source
GLP-1 receptor agonists may improve lung cancer outcomes
Lung cancer patients who take medications called GLP-1 receptor agonists—commonly prescribed for weight loss and diabetes management—fare better than those who don't, according to research led by Sai Yendamuri, MD, MBA, FACS, Chair of Thoracic Surgery at Roswell Park Comprehensive Cancer Center, and Joseph Barbi, Ph.D., Assistant Professor, Department of Immunology.
September 9, 2025 — Source
Popular diabetes drug shows anti-aging effects among patients with type 2 diabetes
Telomeres are protective caps made of repetitive DNA sequences that sit at the ends of our chromosomes. Shortening of telomeres over time is a well-recognized marker of aging and an indicator of potential DNA damage.
September 9, 2025 — Source
Diabetes: Treating Wounds and Injuries
No matter how small or superficial a wound is, you should not ignore it if you have diabetes, says Daniel Cohen, DPM, a podiatrist with Medical Associates of Brevard in Brevard County, Fla. If you stub your toe, get a blister from tight shoes, or nick your chin while shaving, you probably give it little thought. But if you have diabetes, you should seek proper treatment.
Provides Information — Source